Search results
Results From The WOW.Com Content Network
Dimethyl sulfone (DMSO 2) is an organosulfur compound with the formula (CH 3) 2 SO 2. It is also known by several other names including methyl sulfone and (especially in alternative medicine) methylsulfonylmethane (MSM). [4] This colorless solid features the sulfonyl functional group and is the simplest of the sulfones. It is relatively inert ...
Ethyl methanesulfonate, dimethyl sulfone, dimethyl sulfate Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify ( what is Y N ?)
Impure dimethyl sulfate was prepared in the early 19th century. [4] J. P. Claesson later extensively studied its preparation. [5] [6]It was investigated for possible use in chemical warfare in World War I [7] [8] in 75% to 25% mixture with methyl chlorosulfonate (CH 3 ClO 3 S) called "C-stoff" in Germany, or with chlorosulfonic acid called "Rationite" in France.
dimethyl sulfoxide + H 2 O + NAD + dimethyl sulfone + NADH + H + Dimethylsulfone reductase is a molybdoprotein. References External links. Dimethylsulfone+reductase ...
In organic chemistry, a sulfone is a organosulfur compound containing a sulfonyl (R−S(=O) 2 −R’) functional group attached to two carbon atoms. The central hexavalent sulfur atom is double-bonded to each of two oxygen atoms and has a single bond to each of two carbon atoms, usually in two separate hydrocarbon substituents .
The bond dissociation energies for dimethyl sulfide and dimethyl ether are respectively 73 and 77 kcal/mol (305 and 322 kJ/mol). Sulfides are typically prepared by alkylation of thiols. Alkylating agents include not only alkyl halides, but also epoxides, aziridines, and Michael acceptors. [6] They can also be prepared via the Pummerer ...
Sodium methylsulfinylmethylide (also called NaDMSO or dimsyl sodium) is the sodium salt of the conjugate base of dimethyl sulfoxide. This unusual salt has some uses in organic chemistry as a base and nucleophile. Since the first publication in 1965 by Corey et al., [2] a number of additional uses for this reagent have been identified. [3]
Busulfan was approved by the US Food and Drug Administration (FDA) for treatment of chronic myeloid leukemia (CML) in 1999. Busulfan was the mainstay of the chemotherapeutic treatment of chronic myeloid leukemia (CML) until it was displaced by the new gold standard, imatinib, though it is still in use to a degree as a result of the drug's relative low cost.